Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009340 · ClinicalTrials.gov registry record
Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery
A clinical trial of Post-discharge Outcomes, sponsored by Renibus Therapeutics.
- Active
- Registry status
- 200
- Enrollment target
- 4
- Study locations
NCT07009340: Active study of Post-discharge Outcomes, sponsored by Renibus Therapeutics.
NCT07009340 is a study of Post-discharge Outcomes that is active but no longer recruiting, run by Renibus Therapeutics. The registered enrollment target is 200 participants. The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07009340, a study of Post-discharge Outcomes, is active but no longer recruiting, sponsored by Renibus Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.
Primary Outcome
Readmission for any reason Rehospitalization related to procedure/valve/heart failure Contacts with HCP post discharge (any HCP) PCP (if available) All tests and procedures post discharge Medications Chronic kidney disease (CKD) - new diagnosis Acute kidney injury (AKI) requiring dialysis Chronic Kidney disease (CKD) requiring dialysis Atrial fibrillation - new-onset Myocardial infarction (MI) Non-fatal cardiac arrest Reoperation for coronary artery bypass graft (CABG) Reoperation for valve dysf
Conditions Studied
Study Locations (4)
Alabama
- Heart Center Research, LLC - Huntsville
Indiana
- Lutheran Medical Center - Fort Wayne
Michigan
- My Michigan Medical Center - Midland
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-18 |
| Est. Completion | 2025-06-30 |
What the registry record for NCT07009340 still lists
NCT07009340 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Post-discharge Outcomes appearing as the primary indexed condition, and to 0 interventions.
NCT07009340 reports a single indexed study location in Alabama, Indiana, Michigan.
Frequently Asked Questions
What is clinical trial NCT07009340 about?
NCT07009340 is a clinical study titled "Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery". This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.
What is the current status of trial NCT07009340?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2023-11-18. Estimated completion is 2025-06-30.
What conditions does trial NCT07009340 study?
This clinical trial studies the following conditions: Post-discharge Outcomes.
Who is sponsoring clinical trial NCT07009340?
This trial is sponsored by Renibus Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009340 being conducted?
This trial has 4 study locations across Alabama, Indiana, Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI